BRCA2 and neoplasm: The tumor had genomic patterns of Substitution Signature 3, Rearrangement Signatures 2 and 3 and loss of BRCA1 gene expression, all characteristic of BRCA1- but not BRCA2-deficient tumors24,27 (Fig. 2e).